Schonfeld Strategic Advisors’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.94M | Buy |
138,751
+57,242
| +70% | +$800K | 0.01% | 928 |
|
|
2025
Q1 | $1.1M | Sell |
81,509
-589,091
| -88% | -$7.94M | 0.01% | 1132 |
|
|
2024
Q4 | $12.9M | Sell |
670,600
-92,518
| -12% | -$1.77M | 0.07% | 227 |
|
|
2024
Q3 | $17.4M | Buy |
763,118
+617,365
| +424% | +$14M | 0.12% | 138 |
|
|
2024
Q2 | $1.9M | Sell |
145,753
-18,260
| -11% | -$238K | 0.01% | 823 |
|
|
2024
Q1 | $2.87M | Sell |
164,013
-14,906
| -8% | -$261K | 0.02% | 714 |
|
|
2023
Q4 | $3.9M | Buy |
178,919
+70,882
| +66% | +$1.54M | 0.03% | 532 |
|
|
2023
Q3 | $1.66M | Buy |
108,037
+84,670
| +362% | +$1.3M | 0.01% | 764 |
|
|
2023
Q2 | $556K | Buy |
+23,367
| New | +$556K | ﹤0.01% | 1155 |
|
|
2023
Q1 | – | Sell |
-31,400
| Closed | -$917K | – | 2578 |
|
|
2022
Q4 | $917K | Sell |
31,400
-21,223
| -40% | -$620K | 0.01% | 1193 |
|
|
2022
Q3 | $945K | Buy |
+52,623
| New | +$945K | 0.01% | 1291 |
|
|
2022
Q1 | – | Sell |
-21,512
| Closed | -$425K | – | 2730 |
|
|
2021
Q4 | $425K | Sell |
21,512
-22,488
| -51% | -$444K | ﹤0.01% | 1275 |
|
|
2021
Q3 | $724K | Buy |
+44,000
| New | +$724K | 0.01% | 1026 |
|